Help your patients to

Delight

in the everyday

Targeted treatment for mucositis

Mucosamin helps to relieve the pain caused by, and treat the symptoms of: oral mucositis, dry mouth and burning mouth syndrome; as well as aid wound healing, and protect the healthy tissue.

Mucositis describes inflammatory and/or ulcerative lesions of the mucosa, which often result from chemotherapeutic agents or radiation.1 It is a common complication of cancer treatments, which can have significant, and sometimes dose-limiting, consequences.2 

Dry mouth can be a long-term side effect of cancer treatment, which can have a huge impact on a patient’s quality of life.

Mucosamin protects the healthy oral mucosa, whilst providing pain relief and promoting wound healing of painful lesions.

Mucosamin Range

There are two Mucosamin products in the range, which contain sodium hyaluronate and amino acids.

For oral mucositis, Mucosamin Mouthwash soothes and protects the oral mucosa, and Mucosamin Oral Spray provides fast, targeted relief where, and when it is needed. Both of these products help to relieve the symptoms of dry mouth as a result of oral mucositis, whilst providing pain relief and accelerated3 wound healing of oral lesions.

Find out more

What is Mucosamin?

Mucosamin is a medical device made up of sodium hyaluronate and four synthetic amino acids (glycine, L-proline, L-leucine and L-lysine), to protect, relieve and heal the oral mucosa it is targeting.

Discover more about mucositis, Mucosamin and its mode of action, but also, how it works before, during and after treatment to help your patients get back to life.

Find out more

Resources

Visit the Mucosamin Resource Centre for any additional information you need about Mucosamin, such as:

  • Supporting evidence
  • Product data
  • Downloadable patient leave pieces
Find out more

References

Peterson, D. et al. on behalf of the ESMO Guidelines Committee Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up, Annals of Oncology, Volume 26, Issue suppl_5, September 2015, Pages v139–v151, https://doi.org/10.1093/annonc/mdv202
(Accessed May 2023).

Oral Cancer Foundation. Mucositis. https://oralcancerfoundation.org/complications/mucositis/ (Accessed May 2023).

Favia, G. et al. Accelerated wound healing of oral soft tissues and angiogenic effect induced by a pool of amino acids combined to sodium hyaluronate (Aminogam). J Biol Regul Homeost Agents. 2008: 22(2): 109-116

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148.

MUC1010461J1_MAY2023